Computer Motion Second Quarter Earnings Call Scheduled for Monday, July 15th; Call Will Begin at 1:30 p.m. PT.

Business Editors & Health/Medical Writers

Computer Motion, Inc. (Nasdaq:RBOT), the world's leading developer of surgical robotic systems serving over 900 customers and 3,000 surgeons in 32 countries, will conduct a conference call with analysts and investors following the release of its second quarter 2002 earnings on Monday, July 15, 2002 at 1:30 p.m. PT. The conference call will be conducted by Bob Duggan, Chairman and Chief Executive Officer, Eugene W. Teal, Chief Financial Officer, and Darrin Uecker, Chief Operating Officer.

The conference call will be webcast over the Internet. To listen to the call, please visit the Computer Motion Investor Relations website and click on the link under the events section. The address for the Computer Motion Investor Relations page is http://investor.computermotion.com. The webcast will be recorded and available for playback until 5:00 p.m. PT, July 29, 2002.

Second quarter 2002 financial results will be released approximately one half hour prior to the conference call. The press release will be available through Business Wire and the Computer Motion website.

Computer Motion's products include: the ZEUS(R) Robotic Surgical System for minimally invasive surgery, the HERMES(TM) Control Center, a centralized system that enables the surgeon to voice control a network of "smart" medical devices, and the AESOP(R) Robotic Endoscope Positioner, which was also the first surgical robot to be made commercially available in the U.S. The company's newest product, the SOCRATES(TM) Telecollaboration System, is the first device in the newly created FDA category of Robotic Telemedicine Devices, and is designed to facilitate surgeon collaboration using video and audio conferencing, shared control of the endoscopic camera, and video annotation on the surgical image in the operating room. The company's products are CE-Marked for commercial sale in the European Community. The company's Web site is www.ComputerMotion.com.

This press release contains forward-looking statements concerning the company's business and products. Actual results may differ materially depending on a number of risk factors, including the risks of competition and competing technologies, duration or suspension of clinical studies, regulatory clearances and approvals, and physician, hospital and payor acceptance of the company's products. These factors and other risks inherent in the company's business are described from time to time in the company's Securities and Exchange Commission filings, including its Annual Report on Form 10-K. The company undertakes no obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof to reflect the occurrence of unanticipated events.